2 September 2010

Option deal boosts ImmuPharma 

25/11/2008 Robert Tyerman

US pharmaceutical group Cephalon is to pay drug discoverer ImmuPharma £10 million upfront for an option on its Lupuzor lupus treatment.

The option deal gives Cephalon the right to obtain an exclusive worldwide licence for Lupuzor, which treats Lupus Erythematosus, a chronic auto-immune disease that damages skin, joints, blood vessels and the nervous system. If the US company exercises this option, it will then pay AIM-quoted ImmuPharma a one-time licence fee, payments if Lupuzor passes necessary regulatory milestones up to a maximum of £330 million and royalties on subsequent commercial sales.  

ImmuPharma, which lost £1.5 million in the first half of this year, is now conducting a Phase IIb study of Lupuzor on patients in Europe and Latin America. If Cephalon exercises its option, it will take on all expenses for Phase III studies and commercialisation of the product.

Dimitri Dimitriou, chief executive officer of London-based ImmuPharma, proclaims this agreement ‘secures the future for our most advanced asset’.  After a rough ride, ImmuPharma shares, which fell from 84.5p in early 2007 to 36.5p earlier this month, have bounced to 56.5p and should recover further if Lupuzor makes progress.       

Growth Company Investor subscribers have full access to all our AIM and small-cap share recommendations. To subscribe today with a half-price offer, and gain immediate access to all the recommendations, click here.

Sector: Pharmaceuticals & Biotechnology

Companies: ImmuPharma

Subscribe today


More breaking news stories.
More extended feature articles.
And a depth of analysis you
can't find anywhere else.

Subscribe today and save 50%

VCT Report 2010

VCT Report 2010 uncovers the money available

for investment in every single VCT, helping you get one step ahead in the race to attract funding for your unquoted, AIM-listed or PLUS-quoted

company.

Order VCT Report 2010 today using this online form

Cash Shells Directory 2010

A comprehensive overview of cash shells on AIM and PLUS, companies that have become a significant feature on the market landscape. For more information and to order, click here or contact our marketing team on 020 7250 7056.

Coverage of AIM, techMARK and PLUS Markets

Informative features and research on fast-growing companies, small-cap and growth stocks, penny shares, stock market tips and share recommendations, directors' dealings, company news and analysis, new issues and upcoming IPOs.

Take control of your investments

A full year's subscription to What Investment magazine for £19.95, a whopping 58% off. Get the latest news, features and expert advice on ISAs, Investment Trusts and Funds, SIPPS, Investing for Children and much much
more. Find out more here.

The Financial Times Guide to Personal Tax

is the definitive and most up-to-date guide to completing your self-assessment tax return, making sure that you get it right and on time, and showing how you can save tax. For more information and to order, click here or contact our marketing team on 020 7250 7056.

The AIM Guide Spring 2010

The new, fully updated AIM Guide is now available to buy for only £49.95 (saving you £30).

A 'must-have' for any serious investor or professional interested in the market for young, fast-growing companies. Order your copy today Hurry, as offer ends soon!

Latest small-cap and growth company news

Daily coverage of small-cap company stocks on London's junior markets AIM and PLUS, breaking news, stock research and latest share price information for investors. Full sector coverage with all the latest news on smaller listed companies, updated several times a day with financial reports, trading statements and links to further web resources.

Popular News

Latest News

Anglo Asian into profit 02/09/2010

Central Asian gold producer Anglo Asian Mining has turned a $2 million (£1.28 million) interim loss into $6.2 million first-half pre-tax profits.

Tags: AIM , Commodities , Emerging markets , Turnaround

Sector: Mining

Companies: Anglo Asian Mining

Interim advance at Abbey Protection 02/09/2010

Legal fees and related insurance and services specialist Abbey Protection has increased first-half pre-tax profits 9.3 per cent to £4.7 million.

Tags: AIM , Growth Stocks , Mergers & acquisitions

Sector: Nonlife Insurance

Companies: Abbey Protection

Johnson Service on the prowl 01/09/2010

Workwear rental and facilities management concern Johnson Service Group is feeling acquisitive after losing a first-half £2.2 million pre-tax.

Tags: Deals & contracts , Mergers & acquisitions , Turnaround

Sector: Support Services

Companies: Johnson Service

More News

Sectors

Vitesse Media Events